CN115161372A - Method and application of ultrasonic-assisted compound enzymatic hydrolysis to extract soybean peptides with hypoglycemic activity - Google Patents
Method and application of ultrasonic-assisted compound enzymatic hydrolysis to extract soybean peptides with hypoglycemic activity Download PDFInfo
- Publication number
- CN115161372A CN115161372A CN202210982968.3A CN202210982968A CN115161372A CN 115161372 A CN115161372 A CN 115161372A CN 202210982968 A CN202210982968 A CN 202210982968A CN 115161372 A CN115161372 A CN 115161372A
- Authority
- CN
- China
- Prior art keywords
- enzymolysis
- soybean
- ultrasonic
- soybean meal
- supernatant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000068988 Glycine max Species 0.000 title claims abstract description 72
- 235000010469 Glycine max Nutrition 0.000 title claims abstract description 72
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 70
- 150000001875 compounds Chemical class 0.000 title claims abstract description 45
- 238000000034 method Methods 0.000 title claims abstract description 36
- 230000002218 hypoglycaemic effect Effects 0.000 title claims abstract description 24
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 title abstract description 41
- 230000007071 enzymatic hydrolysis Effects 0.000 title abstract description 40
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract description 32
- 235000019764 Soybean Meal Nutrition 0.000 claims abstract description 72
- 239000004455 soybean meal Substances 0.000 claims abstract description 72
- 102000004190 Enzymes Human genes 0.000 claims abstract description 64
- 108090000790 Enzymes Proteins 0.000 claims abstract description 64
- 239000006228 supernatant Substances 0.000 claims abstract description 43
- 239000007788 liquid Substances 0.000 claims abstract description 27
- 238000000265 homogenisation Methods 0.000 claims abstract description 22
- 239000000843 powder Substances 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229940088598 enzyme Drugs 0.000 claims description 61
- 239000004365 Protease Substances 0.000 claims description 58
- 108091005804 Peptidases Proteins 0.000 claims description 30
- 235000019419 proteases Nutrition 0.000 claims description 30
- 239000002131 composite material Substances 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 22
- 102000004142 Trypsin Human genes 0.000 claims description 16
- 108090000631 Trypsin Proteins 0.000 claims description 16
- 239000012588 trypsin Substances 0.000 claims description 16
- 108090000526 Papain Proteins 0.000 claims description 15
- 235000019834 papain Nutrition 0.000 claims description 15
- 229940055729 papain Drugs 0.000 claims description 15
- 108010004032 Bromelains Proteins 0.000 claims description 13
- 102000012479 Serine Proteases Human genes 0.000 claims description 13
- 108010022999 Serine Proteases Proteins 0.000 claims description 13
- 235000019835 bromelain Nutrition 0.000 claims description 13
- 238000005374 membrane filtration Methods 0.000 claims description 12
- 239000003472 antidiabetic agent Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 229940126904 hypoglycaemic agent Drugs 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 2
- 108010007119 flavourzyme Proteins 0.000 claims 2
- 238000000605 extraction Methods 0.000 abstract description 13
- 230000000052 comparative effect Effects 0.000 description 32
- 239000000243 solution Substances 0.000 description 32
- 102000035195 Peptidases Human genes 0.000 description 28
- 235000018102 proteins Nutrition 0.000 description 20
- 102000004169 proteins and genes Human genes 0.000 description 20
- 108090000623 proteins and genes Proteins 0.000 description 20
- 108010073771 Soybean Proteins Proteins 0.000 description 13
- 239000000796 flavoring agent Substances 0.000 description 13
- 235000019634 flavors Nutrition 0.000 description 13
- 230000002538 fungal effect Effects 0.000 description 13
- 239000012528 membrane Substances 0.000 description 13
- 235000019710 soybean protein Nutrition 0.000 description 13
- 239000000047 product Substances 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 10
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 9
- 108010028144 alpha-Glucosidases Proteins 0.000 description 9
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 239000011148 porous material Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 239000012527 feed solution Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical group CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 238000011020 pilot scale process Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 108091005658 Basic proteases Proteins 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000003916 acid precipitation Methods 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 229960003105 metformin Drugs 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- IFBHRQDFSNCLOZ-IIRVCBMXSA-N 4-nitrophenyl-α-d-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C([N+]([O-])=O)C=C1 IFBHRQDFSNCLOZ-IIRVCBMXSA-N 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010049565 Muscle fatigue Diseases 0.000 description 1
- 244000100170 Phaseolus lunatus Species 0.000 description 1
- 235000010617 Phaseolus lunatus Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 238000004807 desolvation Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 235000021070 high sugar diet Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000000110 microvilli Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 125000001151 peptidyl group Chemical group 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- -1 that is Substances 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Water Supply & Treatment (AREA)
- Analytical Chemistry (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Botany (AREA)
- General Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
本发明公开了一种超声波辅助复合酶解提取具有降血糖活性的大豆肽的方法及应用,涉及豆粕提取技术领域,包括以下步骤:S1.获取豆粕粉末;S2.将豆粕粉末分散于水中,进行超高压均质处理,得均质化豆粕液;S3.在超声条件下,利用第一复合酶对均质化豆粕液进行酶解,而后离心分离,得残渣及第一上清液;S4.将残渣分散于水中,加入第二复合酶进行酶解,而后,加入第三复合酶进行酶解,得酶解液,将酶解液离心分离,得第二上清液;S5.将第一上清液及第二上清液混合后浓缩、干燥,即得大豆肽;该方法提取大豆肽的收率高,所得到的大豆肽降糖效果好。The invention discloses a method and application of ultrasonic-assisted compound enzymatic hydrolysis to extract soybean peptides with hypoglycemic activity, and relates to the technical field of soybean meal extraction, comprising the following steps: S1. obtaining soybean meal powder; S2. dispersing the soybean meal powder in water, and performing Ultra-high pressure homogenization treatment to obtain a homogenized soybean meal solution; S3. Under ultrasonic conditions, the homogenized soybean meal solution is enzymatically hydrolyzed by the first compound enzyme, and then centrifuged to obtain a residue and a first supernatant; S4. Disperse the residue in water, add the second compound enzyme to carry out enzymolysis, and then add the third compound enzyme to carry out enzymolysis to obtain an enzymolysis solution, and centrifuge the enzymolysis solution to obtain a second supernatant; S5. The supernatant liquid and the second supernatant liquid are mixed, concentrated and dried to obtain the soybean peptide; the soybean peptide extracted by this method has a high yield, and the obtained soybean peptide has a good hypoglycemic effect.
Description
技术领域technical field
本发明涉及豆粕提取技术领域,尤其涉及一种超声波辅助复合酶解提取具有降血糖活性的大豆肽的方法及应用。The invention relates to the technical field of soybean meal extraction, in particular to a method and application for the extraction of soybean peptides with hypoglycemic activity assisted by ultrasonic-assisted compound enzymolysis.
背景技术Background technique
大豆肽即“肽基大豆蛋白水解物”的简称,是以大豆蛋白经蛋白酶水解或发酵后,再经特殊处理得到的产物,一般有3-6个氨基酸组成,相对分子质量在1000~2000,其必需氨基酸组成与大豆蛋白质完全相同,还包括一些游离氨基酸、少量糖类、水分和灰分等。大豆多肽与大豆蛋白相比,不仅具有与大豆蛋白相同的必需氨基酸,而且比大豆蛋白吸收快,不需要经过胃蛋白酶的酶解,消化吸收直接从小肠开始。能迅速提供能量,具有加速肌肉疲劳恢复的功能。同时具有高浓度、高溶解性、低黏度、高流动性和热稳定性等优良的物理性质。同时,大豆肽粉含有多种生物活性肽,具有多种生理功能,包括抗氧化、降血压、降低胆固醇、降血脂、抗疲劳、增强免疫等。大豆肽对α-葡萄糖苷酶有缓慢抑制作用,α-葡萄糖苷酶分布在肠微绒毛上,它的作用是迅速分解糖供体内葡萄糖,因此,大豆肽与其他碳水化合物、糖类等混合食用时,不受胰岛素分泌量的影响,能起到抑制血糖上升的良好作用,且大豆活性肽富含亮氨酸,能刺激胰岛素分泌,使人体有效地利用自身胰岛素控制血糖浓度。Soybean peptide is the abbreviation of "peptidyl soybean protein hydrolyzate". It is a product obtained by special treatment of soybean protein after protease hydrolysis or fermentation. Its essential amino acid composition is exactly the same as that of soybean protein, and it also includes some free amino acids, a small amount of carbohydrates, moisture and ash. Compared with soybean protein, soybean polypeptide not only has the same essential amino acids as soybean protein, but also absorbs faster than soybean protein. It does not need to undergo enzymatic hydrolysis by pepsin, and digestion and absorption starts directly from the small intestine. It can quickly provide energy and has the function of accelerating muscle fatigue recovery. At the same time, it has excellent physical properties such as high concentration, high solubility, low viscosity, high fluidity and thermal stability. At the same time, soybean peptide powder contains a variety of bioactive peptides, which have a variety of physiological functions, including anti-oxidation, lowering blood pressure, lowering cholesterol, lowering blood lipids, anti-fatigue, and enhancing immunity. Soybean peptide has a slow inhibitory effect on α-glucosidase. α-glucosidase is distributed on the intestinal microvilli. Its function is to rapidly decompose sugar for glucose in the body. Therefore, soybean peptide is mixed with other carbohydrates and sugars. It is not affected by the amount of insulin secretion, and can play a good role in inhibiting the rise of blood sugar, and soybean active peptide is rich in leucine, which can stimulate insulin secretion, so that the body can effectively use its own insulin to control blood sugar concentration.
制备大豆肽的原料主要有三种:大豆粉、大豆分离蛋白和大豆粕。利用大豆粉提取大豆肽,由于大豆中含较多的油脂,用大豆粉制备大豆肽必须先经过脱脂处理,再经酶解处理,获得最终成品,制备过程较复杂,且收率不高;利用大豆分离蛋白提取大豆肽是直接将大豆分离蛋白经酶解处理得到大豆肽成品,该方法制备大豆肽较简单,但是大豆分离蛋白成本较高,且生产大豆分离蛋白的原料一般为豆粕,即豆粕经碱溶酸沉处理后,使蛋白质变性析出,获得的大豆分离蛋白收率较低,且用到较多的酸碱,带来环境污染;而大豆肽是大豆提油后经低温或闪蒸脱溶处理后得到的,其含有的蛋白质变性程度小,且水溶性蛋白质含量高,相关技术中,如公开号为CN1274361C的中国专利大豆肽、制备方法及其应用,公开了可利用豆粕直接除杂后酶解,即可获得大豆肽产物,利用豆粕直接生产大豆肽,省去了生产大豆分离蛋白的环节,简单环保。There are three main raw materials for preparing soybean peptides: soybean meal, soybean protein isolate and soybean meal. Using soybean flour to extract soybean peptides, because soybeans contain more oil, the preparation of soybean peptides from soybean flour must first undergo degreasing treatment, and then undergo enzymatic hydrolysis treatment to obtain the final product. The preparation process is complicated and the yield is not high; using Soybean protein isolate to extract soybean peptide is to directly subject soybean protein isolate to enzymatic hydrolysis to obtain soybean peptide finished product. This method is relatively simple to prepare soybean peptide, but the cost of soybean protein isolate is relatively high, and the raw material for producing soybean protein isolate is generally soybean meal, that is, soybean meal. After alkali-soluble acid precipitation treatment, the protein is denatured and precipitated, the yield of the obtained soybean protein isolate is low, and more acid and alkali are used, which brings environmental pollution; while soybean peptide is extracted from soybean oil after low temperature or flash evaporation The protein obtained after the desolvation treatment has a small degree of protein denaturation and a high water-soluble protein content. In the related art, such as the Chinese patent soybean peptide, preparation method and application with the publication number of CN1274361C, it is disclosed that the soybean meal can be used to directly remove the soybean peptide. After enzymatic hydrolysis, soybean peptide products can be obtained, and soybean peptides can be directly produced by using soybean meal, which saves the link of producing soybean protein isolate, and is simple and environmentally friendly.
但是相关技术以豆粕为提取出的大豆肽的降糖功效不佳。However, the hypoglycemic effect of soybean peptides extracted from soybean meal in the related art is not good.
发明内容SUMMARY OF THE INVENTION
本发明的目的在于,提供一种超声波辅助复合酶解提取具有降血糖活性的大豆肽的方法及应用,所得到的大豆肽降糖效果好。The purpose of the present invention is to provide a method and application for extracting soybean peptides with hypoglycemic activity by ultrasonic-assisted compound enzymolysis, and the obtained soybean peptides have good hypoglycemic effect.
为达到上述技术目的,本申请采用以下技术方案:In order to achieve the above-mentioned technical purpose, the application adopts the following technical solutions:
第一方面,本申请提高一种超声波辅助复合酶解提取具有降血糖活性的大豆肽的方法,包括以下步骤:In the first aspect, the present application improves a method for extracting soybean peptides with hypoglycemic activity by ultrasonic-assisted compound enzymolysis, comprising the following steps:
S1.获取豆粕粉末;S1. Obtain soybean meal powder;
S2.将豆粕粉末分散于水中,进行均质处理,得均质化豆粕液;S2. Disperse the soybean meal powder in water, and carry out homogenization treatment to obtain a homogenized soybean meal liquid;
S3.将豆粕液预热;S3. Preheat the soybean meal liquid;
S4.在超声条件下,利用第一复合酶对均质化预热后豆粕液进行酶解,而后离心得上清液1,上清液1中加入第二复合酶进行酶解,得酶解液,将酶解液离心分离,得上清液2;S4. Under ultrasonic conditions, the homogenized and preheated soybean meal liquid is enzymolyzed by the first compound enzyme, and then centrifuged to obtain supernatant 1, and the second compound enzyme is added to the supernatant 1 for enzymolysis to obtain enzymolysis liquid, the enzymatic hydrolyzate was centrifuged to obtain supernatant 2;
S5.将上清液2浓缩、干燥,即得大豆肽;S5. Concentrate and dry the supernatant 2 to obtain soybean peptide;
其中,第一复合酶为包括丝氨酸蛋白酶、菠萝蛋白酶和木瓜蛋白酶的混合物,第二复合酶为包括胰蛋白酶、霉菌蛋白酶、风味蛋白酶的混合物,所述均质处理的压力为200Mpa-300Mpa,均质次数1-2次,均质温度为50-70℃,更为优选的,均质处理的压力为250Mpa-280Mpa,均质次数2次,均质温度为60-65℃。Wherein, the first composite enzyme is a mixture comprising serine protease, bromelain and papain, the second composite enzyme is a mixture comprising trypsin, fungal protease, and flavor protease, and the pressure of the homogeneous treatment is 200Mpa-300Mpa, and the homogeneous The times are 1-2 times, the homogenization temperature is 50-70°C, more preferably, the pressure of the homogenization treatment is 250Mpa-280Mpa, the homogenization times are 2 times, and the homogenization temperature is 60-65°C.
本申请中,均质处理的压力为“200Mpa-300Mpa”,以下统称为“超高压均质处理”,如本领域技术人员所知,“超高压均质处理”是指,利用超高压均质机对悬浊液状态的物料在超高压作用下,高速流过具有特殊内部结构的容腔,通过挤压、剪切、撞击等作用力使物料中的分子如蛋白质、淀粉等发生物理、化学、结构性质等一系列变化,最终达到均质的效果。In this application, the pressure of the homogenization treatment is "200Mpa-300Mpa", hereinafter collectively referred to as "ultra-high pressure homogenization treatment", as known to those skilled in the art, "ultra-high pressure homogenization treatment" refers to the Under the action of ultra-high pressure, the machine flows through a cavity with a special internal structure at a high speed, and the molecules in the material, such as protein and starch, undergo physical and chemical changes through extrusion, shearing, impact and other forces. , structural properties and a series of changes, and finally achieve a homogeneous effect.
由于豆粕中80%为可溶性蛋白,蛋白质变性后通过超声波工艺可以让蛋白的酶解位点暴露出来,更好的促进酶解反应,提高大豆肽提取收率,将豆粕粉中的蛋白质最大限度的选择性水解,基于以上思路,本方案提取大豆肽的机理为:先利用超高压均质处理,破坏蛋白质的微结构,降低蛋白质颗粒的尺寸大小,为后续的酶解蛋白及蛋白质的溶出降低难度,超声条件下,可使细胞浆流动,细胞震荡,从而使细胞壁变薄或破裂,利于胞内活性成分的释放和提取,也使得胞内活性成分及蛋白质的溶出阻力减小,当蛋白质溶出后,本方案通过分段式复合酶解法,在最大程度范围内将所溶出的蛋白质进行选择性水解为大豆肽。Since 80% of soybean meal is soluble protein, after protein denaturation, the enzymatic hydrolysis site of protein can be exposed by ultrasonic process, which can better promote the enzymatic hydrolysis reaction, improve the extraction yield of soybean peptide, and maximize the protein in soybean meal powder. Selective hydrolysis, based on the above ideas, the mechanism of extracting soybean peptides in this scheme is: firstly use ultra-high pressure homogenization treatment to destroy the microstructure of the protein, reduce the size of the protein particles, and reduce the difficulty for the subsequent enzymolysis of the protein and the dissolution of the protein , Under the condition of ultrasonic, the cytoplasm can flow and the cells vibrate, thereby thinning or breaking the cell wall, which is conducive to the release and extraction of intracellular active components, and also reduces the dissolution resistance of intracellular active components and proteins. , This scheme selectively hydrolyzes the dissolved protein into soybean peptides to the greatest extent through a segmented compound enzymatic hydrolysis method.
在复合酶的组分选择方面,通过发明人的不断努力,对不同种类的酶进行了筛选,胰蛋白酶、木瓜蛋白酶、风味蛋白酶、碱性蛋白酶、胃蛋白酶等,意外的发现,第一复合酶选择为包括丝氨酸蛋白酶、菠萝蛋白酶和木瓜蛋白酶的混合物,第二复合酶选择为包括胰蛋白酶、霉菌蛋白酶、风味蛋白酶的混合物,配合使用,效果最好,提取率最高,三组酶之间具有协同作用。In terms of component selection of composite enzymes, through the continuous efforts of the inventor, different types of enzymes have been screened, such as trypsin, papain, flavor protease, alkaline protease, pepsin, etc. It was unexpectedly discovered that the first composite enzyme The mixture of serine protease, bromelain and papain was selected, and the second compound enzyme was selected as a mixture of trypsin, fungal protease and flavor protease. When used together, the effect was the best, the extraction rate was the highest, and there was synergy among the three groups of enzymes. effect.
值得一提的是,本方案中超高压均质处理还具备为第一复合酶提供更适宜的底物,以增强第一复合酶与底物之间亲和力的作用,进而提高第一复合酶的酶促降解效率;另一方面,由于通过超高压均质处理可破坏蛋白质的二级结构,增加了第二复合酶与底物之间的亲和力,更为顺利的特异性酶解蛋白为大豆肽。It is worth mentioning that the ultra-high pressure homogenization treatment in this scheme also has the effect of providing a more suitable substrate for the first composite enzyme to enhance the affinity between the first composite enzyme and the substrate, thereby improving the enzyme of the first composite enzyme. On the other hand, because the secondary structure of the protein can be destroyed by the ultra-high pressure homogenization treatment, the affinity between the second complex enzyme and the substrate is increased, and the more smoothly specific enzymatically degraded protein is soybean peptide.
优选的,超声的功率为300-600W,超声时间为1-3h,更为优选的,超声的功率为400-500W,超声时间为2-3h。Preferably, the ultrasonic power is 300-600W, and the ultrasonic time is 1-3h. More preferably, the ultrasonic power is 400-500W, and the ultrasonic time is 2-3h.
优选的,步骤S4中,第一复合酶的酶解的pH为4-6,酶解温度为50-60℃,酶解的时间为2-4h。Preferably, in step S4, the pH of the enzymatic hydrolysis of the first compound enzyme is 4-6, the enzymatic hydrolysis temperature is 50-60° C., and the enzymatic hydrolysis time is 2-4 h.
优选的,步骤S4中,第二复合酶的酶解的pH为7.5-8.5,酶解的温度为50-60℃,酶解的时间为2-6h。Preferably, in step S4, the pH of the enzymatic hydrolysis of the second compound enzyme is 7.5-8.5, the temperature of the enzymatic hydrolysis is 50-60°C, and the time of the enzymatic hydrolysis is 2-6 h.
优选的,第一复合酶中,丝氨酸蛋白酶、菠萝蛋白酶和木瓜蛋白酶的质量比为(2-3):(0.5-1):(2-2.5),更为优选的,丝氨酸蛋白酶、菠萝蛋白酶和木瓜蛋白酶的质量比为2:1:2。Preferably, in the first composite enzyme, the mass ratio of serine protease, bromelain and papain is (2-3):(0.5-1):(2-2.5), more preferably, serine protease, bromelain and papain The mass ratio of papain was 2:1:2.
优选的,第二复合酶中,胰蛋白酶、霉菌蛋白酶、风味蛋白酶的质量比为(1.5-2):(2-2.5):(0.1-0.2),更为优选的,胰蛋白酶、霉菌蛋白酶、风味蛋白酶的质量比为2:2:0.2。Preferably, in the second composite enzyme, the mass ratio of trypsin, fungal protease and flavor protease is (1.5-2):(2-2.5):(0.1-0.2), more preferably, trypsin, fungal protease, The mass ratio of flavor protease was 2:2:0.2.
优选的,步骤S4中,离心分离的转速为20000-30000r/min,离心温度为25±5℃,离心时间为10-20min。Preferably, in step S4, the rotational speed of centrifugation is 20000-30000r/min, the centrifugation temperature is 25±5°C, and the centrifugation time is 10-20min.
优选的,步骤S5中,浓缩的方式为膜过滤,膜过滤中的膜孔径为500-3000D,膜过滤的温度为20-30℃;更为优选的,膜过滤所用的膜孔径为500-1000D。Preferably, in step S5, the method of concentration is membrane filtration, the pore size of the membrane in the membrane filtration is 500-3000D, and the temperature of the membrane filtration is 20-30°C; more preferably, the pore size of the membrane used in the membrane filtration is 500-1000D .
优选的,第一复合酶与豆粕粉末的质量比为0.5-3:100,第三复合酶与残渣的质量比为0.5-3:100。Preferably, the mass ratio of the first composite enzyme to the soybean meal powder is 0.5-3:100, and the mass ratio of the third composite enzyme to the residue is 0.5-3:100.
根据本发明的第二方面,提供一种大豆肽在降糖药中的应用。According to the second aspect of the present invention, an application of soybean peptide in hypoglycemic drugs is provided.
大豆肽具有对人体小肠壁上α-葡萄糖苷酶有抑制作用,可以起到一定的降血糖作用,可作为降血糖药物的主要成分。Soybean peptide has inhibitory effect on α-glucosidase on the human small intestine wall, can play a certain role in lowering blood sugar, and can be used as the main component of hypoglycemic drugs.
本发明的有益效果是:本方案通过超高压均质及超声协同作用下,对豆粕进行协同性分段复合酶解,反应条件温和,酶解效率高,在最大程度范围内将所溶出的蛋白质进行选择性水解为大豆肽,提取收率高;利用膜过滤对第一上清液和第二上清液的混合物进行浓缩,除去溶液中残余的酶、大分子多糖、小分子无机盐、水等杂质,最大程度的保留大豆肽,实现对大豆肽的脱色、除杂,提高大豆肽的可食性,降糖效果好。The beneficial effects of the invention are as follows: in this scheme, under the synergistic action of ultra-high pressure homogenization and ultrasound, the soybean meal is subjected to synergistic segmented compound enzymolysis, the reaction conditions are mild, the enzymolysis efficiency is high, and the dissolved protein can be dissolved to the greatest extent. Selectively hydrolyzed into soybean peptides, and the extraction yield is high; the mixture of the first supernatant and the second supernatant is concentrated by membrane filtration to remove the residual enzymes, macromolecular polysaccharides, small molecular inorganic salts, water in the solution. and other impurities, retain soybean peptides to the greatest extent, realize decolorization and impurity removal of soybean peptides, improve the edibility of soybean peptides, and have a good hypoglycemic effect.
具体实施方式Detailed ways
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,均属于本发明保护的范围。The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention. Obviously, the described embodiments are only a part of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative efforts shall fall within the protection scope of the present invention.
本申请的实施例提供了一种超声波辅助复合酶解提取具有降血糖活性的大豆肽的方法,包括以下步骤:The embodiments of the present application provide a method for extracting soybean peptides with hypoglycemic activity by ultrasonic-assisted compound enzymolysis, comprising the following steps:
S1.将豆粕片粉碎后过60-80目筛,获得豆粕粉末;S1. Pulverize the soybean meal flakes and pass through a 60-80 mesh sieve to obtain soybean meal powder;
S2.将豆粕粉末分散于15-20倍质量的水中,进行超高压均质处理,超高压均质的压力为200Mpa-300Mpa,均质次数1-2次,均质温度为50-70℃,得均质化豆粕液;S2. Disperse the soybean meal powder in 15-20 times the mass of water, and perform ultra-high pressure homogenization treatment. The pressure of ultra-high pressure homogenization is 200Mpa-300Mpa, the homogenization times are 1-2 times, and the homogenization temperature is 50-70 ℃, to obtain homogenized soybean meal liquid;
S3.将均质化豆粕液在80-100℃条件下预热30min-1h;S3. Preheat the homogenized soybean meal solution at 80-100°C for 30min-1h;
S4.在超声的功率为300-600W,超声时间为1-3h条件下,利用第一复合酶对均质化豆粕液进行酶解,pH为4-6,50-60℃下酶解2-4h,而后将酶解液于25±5℃下20000-30000r/min离心10-20min以分离得上清液1,将上清液1调节pH为7.5-8.5,50-60℃加入第二复合酶进行酶解2-6h,得酶解液,将酶解液于25±5℃下20000-30000r/min离心10-20min以分离,得上清液2;S4. Under the condition that the ultrasonic power is 300-600W and the ultrasonic time is 1-3h, the homogenized soybean meal liquid is enzymatically hydrolyzed by the first compound enzyme, the pH is 4-6, and the enzymatic hydrolysis is 2- 4h, then centrifuge the enzymatic hydrolysis solution at 20000-30000r/min for 10-20min at 25±5℃ to separate the supernatant 1, adjust the pH of the supernatant 1 to 7.5-8.5, add the second compound at 50-60℃ The enzyme is hydrolyzed for 2-6 hours to obtain an enzymatic hydrolysis solution, and the enzymatic hydrolysis solution is centrifuged at 20000-30000 r/min for 10-20 min at 25±5°C to separate, and supernatant 2 is obtained;
S5.将上清液2浓缩、干燥,即得大豆肽;S5. Concentrate and dry the supernatant 2 to obtain soybean peptide;
其中,第一复合酶为丝氨酸蛋白酶、菠萝蛋白酶和木瓜蛋白酶的混合物,第二复合酶为包括胰蛋白酶、霉菌蛋白酶、风味蛋白酶的混合物。Wherein, the first complex enzyme is a mixture of serine protease, bromelain and papain, and the second complex enzyme is a mixture including trypsin, fungal protease, and flavor protease.
在一些实施例中,第一复合酶中,丝氨酸蛋白酶、菠萝蛋白酶和木瓜蛋白酶的质量比(2-3):(0.5-1):(2-2.5)。In some embodiments, in the first complex enzyme, the mass ratio of serine protease, bromelain and papain is (2-3):(0.5-1):(2-2.5).
在一些实施例中,第二复合酶中,胰蛋白酶、霉菌蛋白酶、风味蛋白酶的质量比为(1.5-2):(2-2.5):(0.1-0.2)。In some embodiments, in the second composite enzyme, the mass ratio of trypsin, fungal protease, and flavor protease is (1.5-2):(2-2.5):(0.1-0.2).
在一些实施例中,第一复合酶与豆粕的质量比为0.5-3:100,第二复合酶与豆粕的质量比为0.5-3:100。In some embodiments, the mass ratio of the first composite enzyme to soybean meal is 0.5-3:100, and the mass ratio of the second composite enzyme to soybean meal is 0.5-3:100.
在一些实施例中,步骤S5中,浓缩的方式为膜过滤,膜过滤中的膜孔径为150-300D,膜过滤的温度为20-30℃。In some embodiments, in step S5, the method of concentration is membrane filtration, the membrane pore size in membrane filtration is 150-300D, and the temperature of membrane filtration is 20-30°C.
在一些实施例中,干燥的方式为喷雾干燥。In some embodiments, the method of drying is spray drying.
本申请的实施例还提供了大豆肽在降糖药中的应用。The embodiments of the present application also provide the application of soybean peptides in hypoglycemic agents.
实施例1Example 1
一种超声波辅助复合酶解提取具有降血糖活性的大豆肽的方法,包括以下步骤:A method for ultrasonic-assisted compound enzymolysis to extract soybean peptides with hypoglycemic activity, comprising the following steps:
S1.将1kg豆粕片研磨粉碎后过60目筛,得豆粕粉末;S1. 1kg soybean meal flakes are ground and pulverized and crossed through a 60 mesh sieve to obtain soybean meal powder;
S2.将豆粕粉末分散于20倍质量的水中,并将悬浊液置于200Mpa的超高压均质机中于70℃下均质2次,得均质化豆粕液;S2. Disperse the soybean meal powder in 20 times the mass of water, and place the suspension in a 200Mpa ultra-high pressure homogenizer to homogenize twice at 70°C to obtain a homogenized soybean meal solution;
S3.将均质化的豆粕液在升温至100℃,维持30min;S3. The homogenized soybean meal liquid is heated to 100°C and maintained for 30min;
S4.将均质化豆粕液在300W功率下超声的同时,加入0.5%豆粕质量的第一复合酶对均质化豆粕液进行酶解,酶解的pH为4,温度为50℃,酶解2h,酶解过程中,维持料液的温度为50℃,将酶解液于25℃下30000r/min离心10min以分离,得第一上清液,而后,再调节第一上清液pH为7.5,加入0.5%豆粕质量的第二复合酶继续酶解2h,酶解过程中,维持料液的温度为50℃,得酶解液,将酶解液于25℃下30000r/min离心10min以分离,得第二上清液,其中,第二复合酶为质量比为2:1:2的丝氨酸蛋白酶、菠萝蛋白酶和木瓜蛋白酶的混合物,第三复合酶为质量比为2:2:0.2的胰蛋白酶、霉菌蛋白酶、风味蛋白酶的混合物;S4. While sonicating the homogenized soybean meal liquid at a power of 300W, add 0.5% soybean meal mass of the first compound enzyme to perform enzymatic hydrolysis on the homogenized soybean meal liquid. The pH of the enzymatic hydrolysis is 4 and the temperature is 50°C. 2h, during the enzymolysis process, the temperature of the feed solution was maintained at 50 °C, and the enzymatic hydrolysis solution was centrifuged at 30,000 r/min for 10 min at 25 °C to separate to obtain the first supernatant, and then the pH of the first supernatant was adjusted to 7.5, add the second compound enzyme of 0.5% soybean meal quality and continue enzymolysis for 2h. During the enzymolysis process, keep the temperature of the feed liquid at 50 °C to obtain the enzymatic hydrolysis solution. Separation to obtain a second supernatant, wherein the second composite enzyme is a mixture of serine protease, bromelain and papain with a mass ratio of 2:1:2, and the third composite enzyme is a mass ratio of 2:2:0.2 Mixture of trypsin, fungal protease, flavor protease;
S5.将第二上清液利用型号为BONA-GM-1818H的多功能有机膜中试设备进行膜浓缩,其中,膜孔径为150D,膜过滤的温度为30℃,再经喷雾干燥机进行喷雾干燥,即得大豆肽。S5. The second supernatant is concentrated by using a multifunctional organic membrane pilot-scale device with a model of BONA-GM-1818H, wherein the membrane pore size is 150D, and the temperature of membrane filtration is 30°C, and then sprayed by a spray dryer. After drying, soybean peptides are obtained.
实施例2Example 2
一种超声波辅助复合酶解提取具有降血糖活性的大豆肽的方法,包括以下步骤:A method for ultrasonic-assisted compound enzymolysis to extract soybean peptides with hypoglycemic activity, comprising the following steps:
S1.将1kg豆粕片研磨粉碎后过80目筛,得豆粕粉末;S1. 1kg soybean meal flakes are ground and pulverized and crossed through an 80 mesh sieve to obtain soybean meal powder;
S2.将豆粕粉末分散于20倍质量的水中,并将悬浊液置于200Mpa的超高压均质机中于70℃下均质2次,得均质化豆粕液;S2. Disperse the soybean meal powder in 20 times the mass of water, and place the suspension in a 200Mpa ultra-high pressure homogenizer to homogenize twice at 70°C to obtain a homogenized soybean meal solution;
S3.将均质化的豆粕液在升温至90℃,维持60min;S3. The homogenized soybean meal liquid is heated to 90°C and maintained for 60min;
S4.将均质化豆粕液在600W功率下超声的同时,加入2%豆粕质量的第一复合酶对均质化豆粕液进行酶解,酶解的pH为5,温度为60℃,酶解时间为4h,而后于30℃下20000r/min离心20min以分离,得残渣及第一上清液,其中,第一复合酶为质量比3:1:2的丝氨酸蛋白酶、菠萝蛋白酶和木瓜蛋白酶的混合物;S4. While sonicating the homogenized soybean meal liquid at a power of 600W, add the first compound enzyme of 2% soybean meal quality to carry out enzymatic hydrolysis of the homogenized soybean meal liquid. The pH of the enzymatic hydrolysis is 5, the temperature is 60 °C, and the The time was 4 h, and then centrifuged at 20000 r/min for 20 min at 30 °C to separate, to obtain the residue and the first supernatant, wherein the first composite enzyme was serine protease, bromelain and papain in a mass ratio of 3:1:2. mixture;
S5.将上清液调节pH为8.5,加入2%豆粕质量的第二复合酶继续酶解6h,酶解过程中,维持料液的温度为60℃,得酶解液,将酶解液于25℃下30000r/min离心20min以分离,得第二上清液,其中,第三复合酶为质量比2:2.5:0.2的胰蛋白酶、霉菌蛋白酶、风味蛋白酶的混合物;S5. Adjust the pH of the supernatant to 8.5, add the second compound enzyme of 2% soybean meal quality and continue enzymolysis for 6 hours. During the enzymolysis process, keep the temperature of the feed liquid at 60°C to obtain an enzymolysis solution, and put the enzymolysis solution in Centrifuge at 30,000 r/min for 20 min at 25°C to obtain a second supernatant, wherein the third composite enzyme is a mixture of trypsin, fungal protease, and flavor protease with a mass ratio of 2:2.5:0.2;
S5.将第二上清液利用型号为BONA-GM-1818H的多功能有机膜中试设备进行膜浓缩,其中,膜孔径为500D,膜过滤的温度为30℃,再经喷雾干燥机进行喷雾干燥,即得大豆肽。S5. The second supernatant is concentrated by using a multifunctional organic membrane pilot-scale equipment with a model of BONA-GM-1818H, wherein the membrane pore size is 500D, and the temperature of membrane filtration is 30°C, and then sprayed by a spray dryer. After drying, soybean peptides are obtained.
实施例3Example 3
一种超声波辅助复合酶解提取具有降血糖活性的大豆肽的方法,包括以下步骤:A method for ultrasonic-assisted compound enzymolysis to extract soybean peptides with hypoglycemic activity, comprising the following steps:
S1.将1kg豆粕片研磨粉碎后过70目筛,得豆粕粉末;S1. 1kg soybean meal flakes are ground and pulverized and then crossed a 70 mesh sieve to obtain soybean meal powder;
S2.将豆粕粉末分散于20倍质量的水中,并将悬浊液置于300Mpa的超高压均质机中于60℃下均质2次,得均质化豆粕液;S2. Disperse the soybean meal powder in 20 times the mass of water, and place the suspension in a 300Mpa ultra-high pressure homogenizer for 2 times at 60°C to obtain a homogenized soybean meal solution;
S3.将均质化的豆粕液在升温至80℃,维持60min;S3. The homogenized soybean meal liquid is heated to 80°C and maintained for 60min;
S4.将均质化豆粕液在400W功率下超声的同时,加入1%豆粕质量的第一复合酶对均质化豆粕液进行酶解,酶解的pH为6.0,温度为55℃,酶解时间为3h,而后于25℃下20000r/min离心10min以分离,得残渣及第一上清液,其中,第一复合酶为质量比为2:0.5:2的丝氨酸蛋白酶、菠萝蛋白酶和木瓜蛋白酶的混合物;S4. While sonicating the homogenized soybean meal liquid at a power of 400W, add the first compound enzyme of 1% soybean meal quality to carry out enzymatic hydrolysis of the homogenized soybean meal liquid. The pH of the enzymatic hydrolysis is 6.0, the temperature is 55° C. The time is 3h, and then centrifuged at 20000r/min for 10min at 25°C to separate, to obtain the residue and the first supernatant, wherein the first compound enzyme is serine protease, bromelain and papain with a mass ratio of 2:0.5:2 mixture;
S5.将上述上清液调节料液的pH为8,加入1%豆粕质量的第二复合酶继续酶解4h,酶解过程中,维持料液的温度为55℃,得酶解液,将酶解液于25℃下20000r/min离心15min以分离,得第二上清液,第三复合酶为质量比1.5:2:0.1的胰蛋白酶、霉菌蛋白酶、风味蛋白酶的混合物;S5. Adjust the pH of the feed solution to 8 with the above-mentioned supernatant, add the second compound enzyme of 1% soybean meal quality and continue enzymolysis for 4 hours. During the enzymolysis process, maintain the temperature of the feed solution at 55°C to obtain an enzymolysis solution, which is The enzymatic hydrolyzate was centrifuged at 20,000 r/min for 15 min at 25°C to obtain the second supernatant, and the third composite enzyme was a mixture of trypsin, fungal protease and flavor protease with a mass ratio of 1.5:2:0.1;
S6.将第二上清液利用型号为BONA-GM-1818H的多功能有机膜中试设备进行膜浓缩,其中,膜孔径为300D,膜过滤的温度为25℃,再经喷雾干燥机进行喷雾干燥,即得大豆肽。S6. The second supernatant is concentrated by using a multifunctional organic membrane pilot-scale equipment with a model of BONA-GM-1818H, wherein the membrane pore size is 300D, and the temperature of membrane filtration is 25°C, and then sprayed by a spray dryer. After drying, soybean peptides are obtained.
对比例1Comparative Example 1
其他步骤与实施例1相同,所不同的是,将步骤S4替换为步骤:调节上清液pH为7.5,加入0.5%豆粕质量的第二复合酶酶解2h,酶解过程中,维持料液的温度为50℃,得酶解液,将酶解液于25℃下30000r/min离心10min以分离,得第二上清液,其中,第二复合酶为质量比为2:2:0.2的胰蛋白酶、霉菌蛋白酶、风味蛋白酶的混合物。The other steps are the same as in Example 1, the difference is that step S4 is replaced by the following steps: adjusting the pH of the supernatant to 7.5, adding 0.5% soybean meal quality second compound enzyme for 2h enzymatic hydrolysis, and maintaining the feed solution during the enzymatic hydrolysis process The temperature is 50 °C to obtain an enzymatic hydrolysis solution, and the enzymatic hydrolysis solution is centrifuged at 30,000 r/min for 10 min at 25 °C to separate, to obtain a second supernatant, wherein the second composite enzyme is a mass ratio of 2:2:0.2 Mixture of trypsin, fungal protease, flavored protease.
对比例2Comparative Example 2
其他步骤与实施例1相同,所不同的是,将步骤S3The other steps are the same as in Embodiment 1, the difference is that step S3
S4替换为步骤:将均质化且100℃加热30min的豆粕液加入0.5%豆粕质量的第一复合酶对豆粕液进行酶解,酶解的pH为5,温度为50℃,酶解时间为4h,而后于25℃下30000r/min离心10min以分离,得残渣及第一上清液,其中,第一复合酶为质量比为1:1:1的胰蛋白酶、霉菌蛋白酶、风味蛋白酶的混合物。S4 is replaced with a step: adding the homogenized soybean meal solution heated at 100 °C for 30 min to the first compound enzyme of 0.5% soybean meal quality to carry out enzymatic hydrolysis of the soybean meal solution, the pH of the enzymatic hydrolysis is 5, the temperature is 50 °C, and the enzymatic hydrolysis time is 4h, and then centrifuged at 30000r/min for 10min at 25°C to obtain the residue and the first supernatant, wherein the first compound enzyme is a mixture of trypsin, fungal protease and flavor protease with a mass ratio of 1:1:1 .
对比例3Comparative Example 3
其他步骤与实施例1相同,所不同的是,将步骤S4替换为步骤:将均质化且100℃加热30min豆粕液在400W超声的同时,加入1%豆粕质量的第一复合酶,酶解的pH为4.5,温度为55℃,酶解时间为3h,而后于25℃下20000r/min离心10min以分离,得残渣及第一上清液,其中,第一复合酶为质量比为2:1:2的丝氨酸蛋白酶、菠萝蛋白酶和木瓜蛋白酶的混合物;The other steps are the same as in Example 1, the difference is that step S4 is replaced by a step: the homogenized and heated soybean meal solution at 100° C. for 30 min is sonicated at 400 W, and the first compound enzyme of 1% soybean meal quality is added to enzymatically hydrolyze the solution. The pH is 4.5, the temperature is 55°C, and the enzymolysis time is 3h, and then centrifuged at 20000r/min for 10min at 25°C to separate, to obtain the residue and the first supernatant, wherein, the first compound enzyme is a mass ratio of 2: 1:2 mixture of serine protease, bromelain and papain;
将步骤S4替换为步骤:将上清液1的pH调为8,加入1%残渣质量的第二复合酶继续酶解4h,酶解过程中,维持料液的温度为55℃,得酶解液,将酶解液于25℃下20000r/min离心15min以分离,得第二上清液,其中,第二复合酶为质量比1.5:2:0.1的胰蛋白酶、霉菌蛋白酶、风味蛋白酶的混合物。Replace step S4 with the step: adjust the pH of the supernatant 1 to 8, add the second compound enzyme of 1% residue mass to continue enzymatic hydrolysis for 4 h, during the enzymatic hydrolysis process, maintain the temperature of the feed liquid at 55 ° C to obtain enzymatic hydrolysis. The enzymatic hydrolysis solution was centrifuged at 20,000 r/min for 15 min at 25°C to obtain a second supernatant, wherein the second composite enzyme was a mixture of trypsin, fungal protease and flavor protease with a mass ratio of 1.5:2:0.1 .
对比例4Comparative Example 4
其他步骤与实施例1相同,所不同的是,将步骤S4替换为步骤:将上清液1的pH调为6,同时加入3%豆粕质量的第二复合酶进行酶解4h,酶解过程中,维持料液的温度为60℃,得酶解液,将酶解液于25℃下30000r/min离心20min以分离,得第二上清液,其中,第一复合酶为质量比3:1:2的丝氨酸蛋白酶、菠萝蛋白酶和木瓜蛋白酶的混合物,第二复合酶为质量比2:2.5:0.2的胰蛋白酶、霉菌蛋白酶、风味蛋白酶的混合物。The other steps are the same as in Example 1, the difference is that step S4 is replaced by the step: the pH of the supernatant 1 is adjusted to 6, and the second compound enzyme of 3% soybean meal quality is added to carry out enzymatic hydrolysis for 4 hours. The enzymatic hydrolysis process In, maintain the temperature of feed liquid to be 60 ℃, obtain enzymolysis solution, centrifuge the enzymolysis solution for 20min at 30000r/min at 25 ℃ to separate, obtain the second supernatant, wherein, the first compound enzyme is mass ratio 3: 1:2 mixture of serine protease, bromelain and papain, and the second composite enzyme is a mixture of trypsin, fungal protease and flavor protease in a mass ratio of 2:2.5:0.2.
对比例5Comparative Example 5
其他步骤与实施例1相同,所不同的是,不包括步骤S2及步骤S3。Other steps are the same as those in Embodiment 1, the difference is that step S2 and step S3 are not included.
对比例6Comparative Example 6
其他步骤与实施例1相同,所不同的是,不包括步骤S3。Other steps are the same as in Embodiment 1, the difference is that step S3 is not included.
对比例7Comparative Example 7
其他步骤与实施例1相同,所不同的是,将步骤S2-步骤S4的步骤顺序调换为步骤S4-步骤S2-步骤S3。The other steps are the same as those in Embodiment 1, the difference is that the sequence of steps S2-S4 is changed to step S4-step S2-step S3.
对比例8Comparative Example 8
其他步骤与实施例1相同,所不同的是,步骤S5中的膜孔径为500D。Other steps are the same as in Example 1, the difference is that the pore size of the membrane in step S5 is 500D.
对比例9Comparative Example 9
1)1kg豆粕片经粉碎、过80目筛得豆粕干粉;1) 1kg soybean meal flakes are pulverized and sieved with 80 meshes to obtain dry soybean meal powder;
2)加入15倍质量的水,用NaOH将pH调至8-11,于50℃搅拌维持1.5h,以30-35r/min加入搅拌,维持1h后,停止搅拌;2) Add 15 times the mass of water, adjust the pH to 8-11 with NaOH, stir at 50°C for 1.5h, add and stir at 30-35r/min, and stop stirring after maintaining for 1h;
3)采用管式离心机离心20min,转速20000r/min,得上清液1和残渣1,残渣1重复步骤2和3,获得上清液2和残渣2;3) Centrifuge with a tubular centrifuge for 20 min at a rotational speed of 20000 r/min to obtain supernatant 1 and residue 1, and repeat steps 2 and 3 for residue 1 to obtain supernatant 2 and residue 2;
4)将上清液1和2合并,并输入酸沉罐中,边搅拌边缓缓加入30%HCl溶液,调pH至5.4。加酸时,需要不断搅拌(搅拌速度为30-40r/min),同时不断抽测pH,当全部溶液达到等电点时应立即停止搅拌,静置20-30min,使蛋白质能形成较大颗粒而沉淀下来;4) Combine the supernatants 1 and 2, and put them into the acid precipitation tank, slowly add 30% HCl solution while stirring, and adjust the pH to 5.4. When adding acid, it needs to be stirred continuously (the stirring speed is 30-40r/min), and at the same time, the pH of the solution should be continuously measured. When the whole solution reaches the isoelectric point, the stirring should be stopped immediately and let stand for 20-30min, so that the protein can form larger particles. settle down;
5)再次采用管式离心机离心20min,转速20000r/min,得上清液3和残渣3,弃上清液;5) Centrifuge again with a tubular centrifuge for 20 min at a rotational speed of 20,000 r/min to obtain supernatant 3 and residue 3, and discard the supernatant;
6)残渣3用50℃的清水洗2次,加入10倍水,用5%NaOH调pH至9.0,加入碱性蛋白酶酶解3h,用HCl调节pH至6.5后升温至90℃以上保持30min灭酶,得大豆肽溶液;6) Residue 3 was washed twice with 50°C water, 10 times of water was added, the pH was adjusted to 9.0 with 5% NaOH, the alkaline protease was added for enzymatic hydrolysis for 3 hours, the pH was adjusted to 6.5 with HCl, and the temperature was raised to above 90°C for 30 minutes. enzyme to obtain soybean peptide solution;
7)将大豆肽稀料液过陶瓷膜后,再过1000D超滤膜,得到的滤液经300D浓缩膜得到产品浓缩液1;7) After passing the soybean peptide dilute feed liquid through the ceramic membrane, then pass through a 1000D ultrafiltration membrane, and the obtained filtrate is passed through a 300D concentrated membrane to obtain a product concentrate 1;
8)将步骤7)中得到的产品浓缩液1过0.22μm孔径滤芯以除去微生物,得到产品浓缩液2;8) passing the product concentrate 1 obtained in step 7) through a 0.22 μm aperture filter to remove microorganisms to obtain product concentrate 2;
9)将步骤8)中得到的产品浓缩液2喷雾干燥(进风200±10℃、出风90±5℃)得到粉末状大豆肽。9) Spray drying the product concentrate 2 obtained in step 8) (inlet air at 200±10° C. and outlet air at 90±5° C.) to obtain powdered soybean peptide.
测试例test case
提取收率测试:首先,称取各实施例或对比例中所得的大豆肽的质量m,再按照《GB/T 22492-2008大豆肽粉》测定各实施例及对比例中大豆肽的纯度w%,最后按照《GB/T5009.5食品中蛋白质的测定方法》测定本实施例及对比例中1kg豆粕中的蛋白总质量M,按照计算公式:提取收率=m*w%/M,对提取收率进行计算,结果如表1所示。Extraction yield test: First, weigh the mass m of the soybean peptides obtained in each example or the comparative example, and then measure the purity w of the soybean peptide in each example and the comparative example according to "GB/T 22492-2008 soybean peptide powder" %, and finally according to "GB/T5009.5 Determination method of protein in food" to measure the total protein mass M in 1 kg of soybean meal in this example and the comparative example, according to the calculation formula: extraction yield=m*w%/M, for The extraction yield was calculated, and the results are shown in Table 1.
表1提取收率结果Table 1 Extraction yield results
降糖效果测试:分别将实施例1-3及对比例1-9所得大豆肽稀释至0.1g/L作为样品溶液,取浓度为0.2U/mLα-葡萄糖苷酶溶液0.1mL加入2mL0.1mol/L磷酸盐缓冲液(pH6.8),37℃水浴15min,加入样品溶液反应10min后再加入0.25mL 25mmol/L底物PNPG,水浴30min后,加入0.1mol/L 2mLNa2CO3终止反应,于400nm处测定吸光度(A2);以1mL磷酸盐缓冲液(pH6.8)替代样品溶液做空白,测其吸光度值为(A0);以0.1mL磷酸盐缓冲液(pH6.8)替代产物中的酶液测定其吸光值为(A1)。重复测定3次,按照公式:α-葡萄糖苷酶抑制率/%=[1-(A2-A1)/A0]*100测得各产物对α-葡萄糖苷酶的抑制率,结果如表2所示。Hypoglycemic effect test: The soybean peptides obtained in Examples 1-3 and Comparative Examples 1-9 were diluted to 0.1 g/L as a sample solution, and 0.1 mL of α-glucosidase solution with a concentration of 0.2 U/mL was added to 2 mL of 0.1 mol/L α-glucosidase solution. L phosphate buffer (pH6.8), water bath at 37°C for 15min, add the sample solution to react for 10min, then add 0.25mL 25mmol/L substrate PNPG, after water bath for 30min, add 0.1mol/L 2mL Na 2 CO 3 to terminate the reaction, Measure the absorbance at 400nm (A2); replace the sample solution with 1 mL of phosphate buffer (pH 6.8) as a blank, and measure the absorbance value (A0); use 0.1 mL of phosphate buffer (pH 6.8) to replace the product in the product. The absorbance value of the enzyme solution was determined as (A1). Repeat the measurement 3 times, according to the formula: α-glucosidase inhibition rate/%=[1-(A2-A1)/A0]*100 to measure the inhibition rate of each product on α-glucosidase, the results are shown in Table 2 Show.
表2对α-葡萄糖苷酶的抑制率Table 2 Inhibition rate of α-glucosidase
大豆肽降糖测试:取SPF级昆明小鼠140只,雌雄各半,3-4w龄,体重18-22g,小鼠饲养于通风良好、相对湿度为50%-60%、室温为23-25℃、严格12h光照12h黑暗的标准化饲养房。小鼠经过3d适应期后,随机对小鼠进行预分组,取12只小鼠作为空白组(BG),饲喂普通饲料。剩余小鼠全部饲喂高脂高糖饲料,喂养1个月后,小鼠禁食12h,按体重100mg/kg剂量予腹腔注射链佐霉素(STZ)溶液(pH4.5,柠檬酸钠缓冲液配制,现配现用),空白组小鼠注射等量柠檬酸钠缓冲液,注射完毕后立刻恢复小鼠饮食,注射72h后尾静脉采血测定空腹血糖值,空腹血糖≥11.1mmol/L且连续多食、多饮、多尿症状的小鼠即为造模成功。取造模成功的小鼠随机分为糖尿病模型组(MG)、二甲双胍组(PG)、大豆肽高剂量组(HDG)、中剂量组(MDG)、低剂量组(LDG),每组12只。高、中、低剂量组分别用实施例1中制得的大豆肽600、400、200mg/kg剂量灌胃;二甲双胍组以二甲双胍200mg/kg剂量灌胃;模型组和空白组灌胃等剂量的超纯水。各组按0.2mL/10g灌胃给药,每天灌胃1次,连续14d,结果见表3。Soybean peptide hypoglycemic test: Take 140 SPF Kunming mice, half male and half male, 3-4w old, weighing 18-22g, and the mice were raised in a well-ventilated, relative humidity of 50%-60%, room temperature of 23-25 ℃, strict 12h light and 12h dark standardized rearing room. After the 3d acclimation period, the mice were randomly divided into pre-groups, and 12 mice were selected as the blank group (BG) and fed with common chow. All the remaining mice were fed a high-fat and high-sugar diet. After 1 month of feeding, the mice were fasted for 12 hours, and were intraperitoneally injected with streptozotocin (STZ) solution (pH 4.5, sodium citrate buffer) at a dose of 100 mg/kg body weight. The mice in the blank group were injected with the same amount of sodium citrate buffer solution, and the mice were restored to their diet immediately after the injection. Blood was collected from the tail vein 72 hours after the injection to measure the fasting blood glucose value. The fasting blood glucose was ≥11.1 mmol/L and The mice with symptoms of continuous polyphagia, polydipsia and polyuria were regarded as successful modeling. The mice with successful modeling were randomly divided into diabetes model group (MG), metformin group (PG), soybean peptide high-dose group (HDG), middle-dose group (MDG), and low-dose group (LDG), with 12 mice in each group. . The high, medium and low dose groups were administered with the soybean peptides prepared in Example 1 at doses of 600, 400, and 200 mg/kg; the metformin group was administered with metformin 200 mg/kg by intragastric administration; the model group and the blank group were administered the same dose of Ultra-pure water. Each group was given 0.2 mL/10 g by intragastric administration, once a day, for 14 consecutive days. The results are shown in Table 3.
表3降糖测试结果Table 3 hypoglycemic test results
感观检测:根据实施例1-3制备的大豆肽,从其口味、颜色、气味三个方面进行感观检测,结果如表4所示,本方案制备的大豆肽感观品质好。Sensory test: The soybean peptides prepared according to Examples 1-3 were sensory tested from three aspects of taste, color and smell. The results are shown in Table 4. The soybean peptides prepared in this scheme have good sensory quality.
表4感观检测Table 4 Sensory detection
结果分析Result analysis
由表1可知,本方案所使用的方法较其他方法而言,提取收率更高,复合酶的添加、超高压均质处理、超声提取三者协同影响提取收率;It can be seen from Table 1 that the method used in this scheme has a higher extraction yield than other methods, and the addition of composite enzymes, ultra-high pressure homogenization treatment, and ultrasonic extraction synergistically affect the extraction yield;
由表2可知,实施例1-3制备的大豆肽对α-葡萄糖苷酶的抑制作用优于对比例1-9,由此可知,本发明方法制备的产品的具有极强的降血糖效果。It can be seen from Table 2 that the soybean peptide prepared in Examples 1-3 has a better inhibitory effect on α-glucosidase than Comparative Examples 1-9. It can be seen that the products prepared by the method of the present invention have extremely strong hypoglycemic effect.
将表2的结果运用于动物实验以验证,以实施例1为研究对象,以市售降糖药物二甲双胍做对比,由表3可看出,使用不同剂量本申请提取的大豆肽,对小鼠的确有降血糖的作用。The results in Table 2 were applied to animal experiments to verify, taking Example 1 as the research object, and comparing with the commercially available hypoglycemic drug metformin. It does have a blood sugar lowering effect.
需要说明的是,以上各实施例均属于同一发明构思,各实施例的描述各有侧重,在个别实施例中描述未详尽之处,可参考其他实施例中的描述。It should be noted that the above embodiments all belong to the same inventive concept, and the description of each embodiment has its own emphasis. For details not described in individual embodiments, reference may be made to descriptions in other embodiments.
以上实施例仅表达了本发明的实施方式,其描述较为具体和详细,但并不能因此而理解为对发明专利范围的限制。应当指出的是,对于本领域的普通技术人员来说,在不脱离本发明构思的前提下,还可以做出若干变形和改进,这些都属于本发明的保护范围。因此,本发明专利的保护范围应以所附权利要求为准。The above examples only represent the embodiments of the present invention, and the descriptions thereof are relatively specific and detailed, but should not be construed as a limitation on the scope of the invention patent. It should be noted that, for those skilled in the art, without departing from the concept of the present invention, several modifications and improvements can be made, which all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention should be subject to the appended claims.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210982968.3A CN115161372A (en) | 2022-08-16 | 2022-08-16 | Method and application of ultrasonic-assisted compound enzymatic hydrolysis to extract soybean peptides with hypoglycemic activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210982968.3A CN115161372A (en) | 2022-08-16 | 2022-08-16 | Method and application of ultrasonic-assisted compound enzymatic hydrolysis to extract soybean peptides with hypoglycemic activity |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115161372A true CN115161372A (en) | 2022-10-11 |
Family
ID=83479498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210982968.3A Pending CN115161372A (en) | 2022-08-16 | 2022-08-16 | Method and application of ultrasonic-assisted compound enzymatic hydrolysis to extract soybean peptides with hypoglycemic activity |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115161372A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117044820A (en) * | 2023-07-24 | 2023-11-14 | 东北农业大学 | Soybean protein isolate hydrolysate and preparation method and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0453460A (en) * | 1990-06-20 | 1992-02-21 | Kotobuki:Kk | Functional food |
CN104164464A (en) * | 2014-08-26 | 2014-11-26 | 南昌大学 | Method for preparing hypoallergenic soybean 7S protein by ultrasonic-assisted enzymolysis deglycosylation |
CN104719611A (en) * | 2013-12-18 | 2015-06-24 | 中粮营养健康研究院有限公司 | Method for preparing soybean peptides through enzymolysis of soy protein |
CN108949887A (en) * | 2018-09-04 | 2018-12-07 | 哈尔滨工业大学 | A kind of preparation method of the multi-functional incretin peptide of soybean |
-
2022
- 2022-08-16 CN CN202210982968.3A patent/CN115161372A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0453460A (en) * | 1990-06-20 | 1992-02-21 | Kotobuki:Kk | Functional food |
CN104719611A (en) * | 2013-12-18 | 2015-06-24 | 中粮营养健康研究院有限公司 | Method for preparing soybean peptides through enzymolysis of soy protein |
CN104164464A (en) * | 2014-08-26 | 2014-11-26 | 南昌大学 | Method for preparing hypoallergenic soybean 7S protein by ultrasonic-assisted enzymolysis deglycosylation |
CN108949887A (en) * | 2018-09-04 | 2018-12-07 | 哈尔滨工业大学 | A kind of preparation method of the multi-functional incretin peptide of soybean |
Non-Patent Citations (5)
Title |
---|
MONTOYA等: "Bioactive Peptides from Germinated Soybean with Anti-Diabetic Potential by Inhibition of Dipeptidyl Peptidase-IV, α-Amylase, and α-Glucosidase Enzymes", 《INT. J. MOL. SCI.》, 22 September 2018 (2018-09-22), pages 2883 - 2897 * |
段双庚;张佳鑫;江明珠;: "响应面法优化超声辅助酶解制备大豆降血糖肽的研究", 食品工程, no. 01, 31 March 2020 (2020-03-31) * |
管风波;宋俊梅;: "大豆肽的开发及其在食品工业中的应用前景", 中国食品添加剂, no. 02, 15 April 2008 (2008-04-15) * |
芦鑫 等: "高温压榨花生饼粕酶法制备抗氧化肽的研究", 《中国粮油学报》, 31 March 2013 (2013-03-31), pages 99 - 104 * |
饶珊 等: "酶解大豆分离蛋白的抗坏血酸改性研究", 《现代食品科技》, 30 March 2005 (2005-03-30), pages 21 - 24 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117044820A (en) * | 2023-07-24 | 2023-11-14 | 东北农业大学 | Soybean protein isolate hydrolysate and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103719880B (en) | Preparation method of high-activity purple sweet potato dietary fiber | |
CN101664167B (en) | Peanut water-soluble dietary fiber enzymatic extracting method | |
CN102212107A (en) | Rice protein polypeptide and preparation method thereof | |
CN100535122C (en) | Method for preparing laver polypeptide based on pretreatment of ultrasonic | |
CN104207150A (en) | Oral liquid containing soybean peptides and fungi polysaccharides and preparation method thereof | |
CN102090639B (en) | Sea cucumber colla corii asini polypeptide nutrient product and preparation method thereof | |
CN111642666A (en) | Preparation method of ginseng extract soybean peptide powder solid beverage | |
CN106282284A (en) | Stichopus japonicus oligopeptide production enzyme and enzymolysis process | |
CN101434980B (en) | Preparation of rice bran short peptide | |
CN110801024A (en) | Polysaccharide composite polypeptide for reducing blood sugar, blood fat and glycosylated hemoglobin and preparation method thereof | |
CN108753894A (en) | A kind of extracting method of American Ginseng peptide | |
CN114196719B (en) | Process for improving hypoglycemic activity of mulberry leaf peptide | |
CN108546281A (en) | A kind of ginseng oligopeptide and its preparation method and application | |
CN104491835A (en) | Assistant hypoglycemic health product containing Prunus padus L. polysaccharide | |
CN112890210B (en) | Protein powder and preparation method thereof | |
CN114134190A (en) | Preparation method of zein active peptide-carried calcium ion nano chelate | |
WO2021078288A1 (en) | Activated insulin, compound momordica charantia peptide oral medicine for treatment of diabetes, and preparation method | |
CN113249421B (en) | A kind of rubyrin polypeptide and its preparation and application | |
CN109288029A (en) | Composite preparation and preparation based on beet water-soluble dietary fiber and glycine betaine | |
CN115161372A (en) | Method and application of ultrasonic-assisted compound enzymatic hydrolysis to extract soybean peptides with hypoglycemic activity | |
CN118575957A (en) | A cell nutrition supplement and preparation method thereof | |
CN106993810A (en) | A kind of Chinese yam soluble dietary fiber and preparation method thereof | |
CN106858613B (en) | Compound spicy xyloglucan polypeptide-amino acid buccal tablet and preparation method thereof | |
CN118853806A (en) | Sweet potato peptide for inhibiting alpha-glucosidase activity and preparation method thereof | |
CN112176015B (en) | Efficient bionic preparation method of sea cucumber bioactive peptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20221011 |